顺铂|T1564

Cisplatin
15663-27-1

￥116 10mg 起订

￥232 50mg 起订

￥348 100mg 起订

上海更新日期：2024-09-14

TargetMol中国（陶术生物）

VIP12年

联系人：邵小姐

电话：021-021-33632979拨打

手机：15002134094 拨打

邮箱：marketing@targetmol.com

产品详情:

中文名称：: 顺铂

英文名称：: Cisplatin

CAS号：: 15663-27-1

品牌：: TargetMol

产地：: 美国

保存条件：: keep away from direct sunlight | Powder: -20°C for 3 years | Shipping with blue ice.

纯度规格：: 99.63%

产品类别：: 抑制剂

货号：: T1564

Product Introduction

Bioactivity

名称	Cisplatin
描述	Cisplatin (CDDP) is a DNA cross-linking agent. Cisplatin has antitumor activity and inhibits DNA synthesis by forming DNA adducts in cancer cells. Cisplatin also activates ferroptosis and induces autophagy.
细胞实验	Rabbit renal proximal tubules were isolated using the iron oxide perfusion method and grown in 35-mm tissue culture dishes under improved conditions as described previously. The cell culture medium was a 1:1 mixture of Dulbecco's modified Eagle's medium/Ham's F-12 (without D-glucose, phenol red, or sodium pyruvate) supplemented with 15 mM HEPES buffer, 2.5 mM L-glutamine, 1 μM pyridoxine HCl, 15 mM sodium bicarbonate, and 6 mM lactate. Hydrocortisone (50 nM), selenium (5 ng/ml), human transferrin (5 μg/ml), bovine insulin (10 nM), and L-ascorbic acid-2-phosphate (50 μM) were added to fresh culture medium immediately before daily media change. In general, confluent RPTCs were treated with inhibitors or diluent control [typically DMSO at 0.1% (v/v)] for 30 min before treatment with cisplatin. Aliquots of RPTCs were used for various assays as detailed below [1].
动物实验	Mice were divided randomly into three groups (Control, Cisplatin and Cisplatin+HemoHIM), and each group consisted of twenty mice. B16F0 melanoma (5 × 10^5 cells/mouse) was inoculated into subcutaneous femoral left region of mice at 3 days before an initial injection of cisplatin. Cisplatin was injected intraperitoneally at 4 mg/kg body weight (B.W.) on day 0, 7 and 14 (total three injections). Experimental group was intubated with HemoHIM at a final concentration of 100 mg/kgB.W. by everyday from day -1 to day 16, while the control group received only water. On day 17 after initial injection of cisplatin, all mice of each group were experimented, respectively, to evaluate tumor weight or tumor size. The tumor size was calculated as follows: tumor size = ab^2/2, where a and b are the larger and smaller diameters, respectively [3].
体外活性	方法：人非小细胞肺癌细胞 A549、SKMES-1、MOR 和 H460 用 Cisplatin (0.001-100 μM) 处理 72 h，使用 MTT 方法检测细胞生长抑制情况。结果：Cisplatin 剂量依赖性地抑制 A549、SKMES-1、MOR 和 H460 细胞生长，IC50 分别为 1.58 µM、4.09 µM、6.39 µM 和 5.72 µM。[1] 方法：人乳腺癌 MCF-7 和 MDA-MB-231 用 Cisplatin (2-10 μg/mL) 处理 48 h，使用 Western Blot 方法检测靶点蛋白表达水平。结果：Cisplatin 剂量依赖性诱导 MCF-7 和 MDA-MB-231 细胞中凋亡相关蛋白 cleaved-caspase 3 和 cleaved-PARP 的水平增加。[2] 方法：间皮瘤细胞 JU77、LO68 和 ONE58 用 Cisplatin (5-100 μg/mL) 处理 24 h，使用 JC-1 染料检测线粒体膜电位 (MMP)。结果：Cisplatin 剂量依赖性降低 JU77、LO68 和 ONE58 细胞的 MMP，抑制线粒体功能。[3]
体内活性	方法：为检测体内抗肿瘤活性，将 Cisplatin (5 mg/kg/6 天) 和 Chloroquine (13 mg/kg/天) 腹腔注射给携带咽下鳞状细胞癌肿瘤 (HSCC) FaDu 的 BALB/c nude 小鼠，持续十八天。结果：Cisplatin 治疗显著抑制 HSCC 肿瘤生长，Chloroquine 抑制自噬并增加 Cisplatin 诱导的细胞凋亡，从而增强了 Cisplatin 的疗效，导致小鼠的肿瘤生长减少和生存期延长。[4] 方法：为减轻 Cisplatin 治疗引起的肾毒性，将 Cisplatin (3-6 mg/kg/3天) 腹腔注射和 Cilastatin (100 mg/kg/天) 皮下注射给人肺腺癌肿瘤 A549 的 BALB/c 小鼠，持续七天。结果：Cilastatin 可以在不影响 Cisplatin 抗肿瘤作用的情况下减少其诱导的肾毒性。[5]
存储条件	keep away from direct sunlight \| Powder: -20°C for 3 years \| Shipping with blue ice.
溶解度	H2O : 1 mg/mL (3.3 mM), Heating at 50℃ is recommended.（DMSO can inactivate Cisplatin's activity.) DMF : 20 mg/mL (66.7 mM)
关键字	cis-Platinum \| drug \| cross-linking \| Ferroptosis \| DNA Alkylator/Crosslinker \| antineoplastic \| damage \| inhibit \| Inhibitor \| chemotherapy \| Cisplatin \| Autophagy \| DNA
相关产品	L-Cystine \| Guanidine hydrochloride \| Naringin \| Taurine \| Gefitinib \| Hydroxychloroquine \| Curcumin \| Stavudine \| Salicylic acid \| Thymidine \| Paeonol \| Sodium 4-phenylbutyrate

cis-Diaminodichloroplatinum|||CDDP|||顺铂|TargetMol

上海陶术生物科技有限公司为美国Target Molecule Corp. ( Target Mol ) 在上海建立的全资子公司。我们与美国波士顿、德国慕尼黑的同事一起，为北美、欧洲和亚洲从事药物研发和生物学研究的科学家提供优质的产品和专业的服务。公司下设筛选事业部，化学事业部，生物事业部和新材料部。从虚拟筛选到实体化合物分子供应；从商业化产品销售到个性化定制合成；从对明确靶点的分子筛选到对明确分子的多靶点筛选，从高通量筛选到化学结构优化，我们都可以满足您的科研用品及技术服务的需求。经过在中国市场五年的精心耕耘，我们已成为筛选化合物领域优秀的供应商，为超过五百家学校和各类企业提供了品质卓越的小分子化合物和药物筛

成立日期	(12年)
注册资本	566.2651万人民币
员工人数	100-500人
年营业额	￥ 1亿以上
经营模式	贸易,试剂,定制,服务
主营行业	化学试剂,生物活性小分子